CYTK
Cytokinetics, Incorporated · Healthcare
Director B Lynne Parshall sold $1.2M of Cytokinetics, Incorporated
Sold$1,239,840
$40.00Price
30,996Shares
−86%Stake
What CYTK did after the filing
- The stock from Mon, Nov 8 open, $41.35
- −1.3%
- S&P 500, same days
- −1.1%
Measured over 30 trading days, to the Dec 21 close.
Traded Fri, Nov 5. Filed Fri, Nov 5, 6:33 PM ET, after the close. Returns use the Nov 8 open and the Dec 21 close. Not investment advice.